Institutional investors purchased a net $688.5 thousand shares of FCSC during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 26.73% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EMERALD ADVISERS, INC. Bought 244.2 Thousand shares of Fibrocell Science Inc
BELMONT GLOBAL ADVISORS, INC. Bought 110.5 Thousand shares of Fibrocell Science Inc
PANAGORA ASSET MANAGEMENT, INC. Bought 66.2 Thousand shares of Fibrocell Science Inc